 | Axsome Therapeutics (NASDAQ:AXSM) Now Covered by Analysts at Berenberg Bank
marketbeat.com - June 10 at 7:29 AM |
| Axsome Therapeutics (NASDAQ:AXSM) Price Target Increased to $105.00 by Analysts at Morgan Stanley
marketbeat.com - May 26 at 8:34 AM |
| Why this is an Awesome Time to Buy Axsome Therapeutics
marketbeat.com - March 1 at 11:17 AM |
 | Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 6.6%
americanbankingnews.com - June 10 at 12:36 PM |
| Axsome Therapeutics (NASDAQ:AXSM) Coverage Initiated by Analysts at Berenberg Bank
americanbankingnews.com - June 10 at 8:30 AM |
 | Why Is Axsome (AXSM) Up 14.7% Since Last Earnings Report?
finance.yahoo.com - June 9 at 1:18 PM |
 | Noteworthy Wednesday Option Activity: AXSM, CELH, IMAX
nasdaq.com - June 2 at 5:46 PM |
| Axsome Therapeutics (NASDAQ:AXSM) PT Raised to $105.00 at Morgan Stanley
americanbankingnews.com - May 26 at 10:24 AM |
| AXSM210618C00062500 (AXSM210618C00062500) stock price, news, quote & history – Yahoo Finance
in.finance.yahoo.com - May 24 at 10:45 PM |
| Axsome's (AXSM) Q1 Earnings Top, AXS-05 Launch in Focus
finance.yahoo.com - May 11 at 3:42 PM |
|
| Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 10:00 AM |
| Why Earnings Season Could Be Great for Axsome Therapeutics (AXSM)
finance.yahoo.com - May 7 at 1:38 PM |
| Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month
finance.yahoo.com - May 7 at 8:38 AM |
| Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
finance.yahoo.com - April 27 at 9:56 AM |
| FDA Begins Priority Review of Axsome Therapeutics' Potential New Depression Drug
nasdaq.com - April 26 at 1:31 PM |
| Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder
finance.yahoo.com - April 26 at 8:31 AM |
| INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Axsome Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - April 24 at 1:54 PM |
 | Is a Beat in Store for CRISPR (CRSP) This Earnings Season?
msn.com - April 23 at 9:14 AM |
| Why Is Axsome (AXSM) Down 19.9% Since Last Earnings Report?
finance.yahoo.com - March 31 at 1:46 PM |
| Oversold Conditions For Axsome Therapeutics
nasdaq.com - March 30 at 5:44 PM |
| Read This Before Selling Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares
finance.yahoo.com - March 30 at 7:31 AM |
| 1 Green Flag for Axsome Therapeutics
finance.yahoo.com - March 11 at 2:33 PM |
 | InvestorNewsBreaks - Axsome Therapeutics, Inc. (NASDAQ: AXSM) Featured in Mizuho Securities Research Report
marketwatch.com - March 5 at 7:44 PM |
| Axsome's (AXSM) Q4 Earnings Miss Estimates, Pipeline in Focus
finance.yahoo.com - March 2 at 2:30 PM |
| Axsome Therapeutics, Inc. (AXSM) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 1 at 7:31 PM |
| Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 1 at 8:21 AM |
| Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
finance.yahoo.com - February 16 at 12:05 PM |
| Forget Bitcoin: This Biotech Stock Is a Better Buy in 2021
finance.yahoo.com - February 10 at 8:37 AM |
|
| Axsome Therapeutics (AXSM) Shares Cross Above 200 DMA
nasdaq.com - February 4 at 1:16 PM |
| AXSM Feb 2021 55.000 put
ca.finance.yahoo.com - January 30 at 6:22 PM |
| AXSM Feb 2021 80.000 call
ca.finance.yahoo.com - January 30 at 8:16 AM |
| AXSM Feb 2021 87.500 put
ca.finance.yahoo.com - January 29 at 7:24 PM |
| AXSM Feb 2021 77.500 call
ca.finance.yahoo.com - January 29 at 7:24 PM |
| Is It Too Late to Get In On This Millionaire-Making Stock?
finance.yahoo.com - January 27 at 9:18 AM |
| Axsome's (AXSM) Migraine Drug Shows Long-Term Safety in Study
finance.yahoo.com - January 4 at 1:01 PM |
 | Axsome Therapeutics Announces Positive Efficacy...
benzinga.com - December 31 at 8:30 AM |
| Axsome Reports Positive Results From Phase 3 Trial Of AXS-07 In Acute Treatment Of Migraine
nasdaq.com - December 31 at 8:30 AM |
| Axsome Therapeutics Begins Phase 3 Trial Of AXS-05 In Alzheimer's Disease Agitation
nasdaq.com - December 31 at 8:30 AM |
| Axsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
finance.yahoo.com - December 31 at 8:30 AM |
| What Kind Of Shareholders Hold The Majority In Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shares?
finance.yahoo.com - December 30 at 8:46 AM |
 | Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run?
markets.businessinsider.com - December 27 at 10:11 PM |
| Axsome Therapeutics Inc Buy
markets.businessinsider.com - December 26 at 9:08 PM |
 | CRSP Jan 2021 110.000 put
uk.finance.yahoo.com - December 26 at 9:08 PM |
| AXSM Mar 2021 90.000 put
in.finance.yahoo.com - December 23 at 1:41 PM |
 | Several High Impact Catalysts For Axsome In H1 2021
seekingalpha.com - December 23 at 8:40 AM |
| AXSM Mar 2021 115.000 call
in.finance.yahoo.com - December 22 at 11:57 PM |
| Noteworthy Tuesday Option Activity: BJRI, AXSM, GILD
nasdaq.com - December 22 at 6:56 PM |
| AXSM Jan 2021 77.500 put
in.finance.yahoo.com - December 21 at 11:55 PM |
 | Axsome Therapeutics Inc
bloomberg.com - December 18 at 10:55 PM |
| AXSM Jan 2022 57.500 call
in.finance.yahoo.com - December 17 at 11:17 PM |
| Is AXSM A Good Stock To Buy Now?
finance.yahoo.com - December 17 at 6:17 PM |
| AXSM Jan 2022 90.000 put
in.finance.yahoo.com - December 16 at 7:49 PM |
| The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
benzinga.com - December 8 at 9:33 AM |
